A congenic C57BL/6J rd1 mouse model for retinal degeneration research
Experimental Eye Research · 2026
DOI: 10.1016/j.exer.2025.110804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2026. Verfasst von Laurel C Chandler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Genetics and Ophthalmology, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA; Howard Hughes Medical Institute, Chev…. Hauptthemen laut MEDLINE: Disease Models, Animal, Cyclic Nucleotide Phosphodiesterases, Type 6, Retinal Degeneration, Retinitis Pigmentosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute, National Institutes of Health, National Eye Institute.
Abstract (Originalsprache)
Retinitis pigmentosa is an inherited retinal disease caused by thousands of mutations in over 100 different genes. The most widely used mouse model for retinitis pigmentosa has the retinal degeneration 1 (rd1) mutation in the Pde6b gene, which elicits rapid retinal degeneration and vision loss. A major limitation of these models is that these rd1 strains are not congenic, which prevents the use of appropriate controls. Furthermore, many strains have mutations in other genes which introduces genetic variability and may confound results. To address this issue, we backcrossed the rd1 allele from FVB mice onto a C57BL/6J genetic background over many generations, producing a C57BL/6J.Pde6brd1 strain that was confirmed to be congenic to C57BL/6J mice. We show that this strain recapitulates the electroretinogram and optomotor results expected for mouse strains containing the rd1 mutation. Examination of retinal structure in cross sections of eyes isolated from C57BL/6J.Pde6brd1 mice show a degree of thinning of the outer nuclear layer expected for a rd1 mutation, resulting in nearly complete loss of the outer nuclear layer by postnatal day 35. We anticipate that this C57BL/6J.Pde6brd1 strain could become an asset for the field of retinitis pigmentosa research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Genetics and Ophthalmology, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD, 20815, USA.
- Departments of Genetics and Ophthalmology, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA; Virology Program, Harvard Medical School, Boston, MA, 02115, USA; Howard Hughes Medical Institute, Chevy Ch…
- Departments of Genetics and Ophthalmology, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD, 20815, USA. Electronic address: cepko@genetics.med.harvar…
Förderung
- Howard Hughes Medical Institute
- National Institutes of Health
- National Eye Institute
- Israel National Road Safety Authority
Zitieren
APA
Chandler, L. C., Gardner, A., & Cepko, C. L. (2026). A congenic C57BL/6J rd1 mouse model for retinal degeneration research. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110804
Vancouver
Chandler LC, Gardner A, Cepko CL. A congenic C57BL/6J rd1 mouse model for retinal degeneration research. Experimental Eye Research. 2026. doi:10.1016/j.exer.2025.110804
BibTeX
@article{Chandler2026,
author = {Chandler, Laurel C and Gardner, Apolonia and Cepko, Constance L},
title = {A congenic C57BL/6J rd1 mouse model for retinal degeneration research},
journal = {Experimental Eye Research},
year = {2026},
doi = {10.1016/j.exer.2025.110804}
}
EUVIMED